Save the date, our sister company’s next webinar will take place on April 15th! Join Luís Raiado and Juliette Ambrosini next month for a brand-new edition tackling challenges posed by microcarrier-based processes in bioprocess development and scale-up.
Adherent cells are widely used to produce viral vaccines. In this context, process development based on bioreactors using microcarriers is the best solution for these cell types to reach volumes required at commercial scales. However, developing related processes and scaling them up is challenging.
Naobios has a long-standing experience working with customers worldwide to develop, optimize and scale up upstream and downstream processes used to manufacture vaccines (both live and inactivated) and oncolytic viruses. Our GMP manufacturing capacity also gives us a comprehensive overview of expectations when building and articulating processes for clinical and commercial purposes.
This webinar aims to show our strategy on how to successfully implement microcarrier based processes and subsequent scale-up to 250L.